¼¼°èÀÇ ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå, ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼ : Åõ¿© °æ·Îº°, Á¦Ç° À¯Çüº°, µ¿¹° À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ¿¹Ãø(2025-2034³â)
Companion Animal Vaccines Market Size, Share, Trends, & Industry Analysis Report By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Product, By Animal Type, By Distribution Channel, By Region - Market Forecast, 2025-2034
Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é ¹Ý·Áµ¿¹° ¹é½Å ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 85¾ï 656¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÅëÂû·Â°ú ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.
¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀº °³, °í¾çÀÌ¿Í °°Àº °¡Ãà ÀÌ¿ÜÀÇ ¹Ý·Áµ¿¹°À» ´Ù¾çÇÑ °¨¿°¼º ÁúȯÀ¸·ÎºÎÅÍ º¸È£Çϱâ À§ÇØ °³¹ßµÈ »ý¹°ÇÐÀû Á¦Á¦·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¹Ý·Áµ¿¹°ÀÇ Àΰ£È°¡ ÁøÇàµÇ°í ¹Ý·Áµ¿¹° º¸È£ÀÚµéÀÌ ¿¹¹æÀû °Ç°°ü¸®¸¦ Á¡Á¡ ´õ Áß¿äÇÏ°Ô »ý°¢ÇÔ¿¡ µû¶ó °è¼Ó ÁøÈÇϰí ÀÖ½À´Ï´Ù. µ¿¹° ¸é¿ªÇÐÀÇ ¹ßÀü°ú Àμö°øÅëÀü¿°º´ÀÇ À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ÇÙ½É ¹é½Å°ú ºñÇÙ½É ¹é½Å ¸ðµÎ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¾÷°è¿¡¼´Â ÄÄÇöóÀ̾𽺠¹× ¾ÈÀü¼ºÀ» ³ôÀ̱â À§ÇØ È¥ÇÕ¹é½Å, ¹«Ä§ ÁÖ»ç±â ¹× °æ±¸¿ë Á¦Çü°ú °°Àº »õ·Î¿î Àü´Þ Ç÷§ÆûÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ý·Áµ¿¹°ÀÇ ¹ÙÀÌ·¯½º ¹× ¼¼±Õ °¨¿°ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¹é½Å °³¹ß, ƯÈ÷ ÀçÁ¶ÇÕ ¹× DNA ±â¹Ý ±â¼úÀÇ Çõ½ÅÀÌ °¡¼Óȵǰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀåÀº ¹Ý·Áµ¿¹° º¸Çè Àû¿ë ¹üÀ§ È®´ë¿Í µ¿¹° ÀÇ·áºñ Áõ°¡·Î ÀÎÇØ °¡¼Óȵǰí ÀÖÀ¸¸ç, ÀÌ´Â ÃÑüÀûÀ¸·Î ¹é½ÅÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´ ±â¾÷µéÀº ÁøÈÇÏ´Â º´¿øÃ¼ ÇÁ·ÎÆÄÀϰú Ç׿ø º¯À̼º¿¡ ´ëÀÀÇÏ¿© Àå½Ã°£ ÀÛ¿ë, ±³Â÷ ¹æ¾î, ±ÕÁÖ Æ¯ÀÌÀû ¹é½ÅÀ» °³¹ßÇϱâ À§ÇØ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ °¨µ¶À» ÅëÇØ Á¦Ç°ÀÇ À¯È¿¼º°ú ¾ÈÀü¼ºÀ» º¸ÀåÇϱâ À§ÇØ Á¦Á¶¾÷ü´Â °íµµÀÇ Ç°Áú º¸ÁõÀ» ½ÇõÇϰí ÀÖ½À´Ï´Ù. ¸ÂÃãÇü µ¿¹° ÀÇ·á¿Í ¹é½Å °³¹ß ÆÄÀÌÇÁ¶óÀο¡ ÀΰøÁö´É(AI)À» Àû¿ëÇÏ´Â °ÍÀº ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃàÇϰí Ÿ°ÙÆÃ Á¤È®µµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ´Â ÁÁÀº ±âȸÀÔ´Ï´Ù. ¹é½Å ÀÎÁöµµ Çâ»ó¿¡ ÀÖ¾î µ¿¹°º´¿ø°ú µðÁöÅÐ Çコ Ç÷§ÆûÀÇ ¿ªÇÒ Áõ°¡´Â Á¦¾àȸ»ç¿Í µ¿¹°º´¿øÀÇ Çù·Â °ü°è Áõ°¡¿Í ÇÔ²² ½ÃÀå È®´ëÀÇ È£À縦 ½Ã»çÇϰí ÀÖ½À´Ï´Ù.
¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå º¸°í¼ÀÇ ÁÖ¿ä ³»¿ë
Á¦Ç°º°·Î´Â 2024³â ¾àµ¶¼º »ý¹é½Å ºÐ¾ß°¡ °·ÂÇÑ ¸é¿ª¿ø¼º°ú ºü¸¥ ¹æ¾î °³½Ã ´É·ÂÀ¸·Î °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
µ¿¹° À¯Çüº°·Î´Â °í¾çÀÌ ¹éÇ÷º´ ¹ÙÀÌ·¯½º(FeLV) ¹× °í¾çÀÌ ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º(FIV)¿Í °°Àº °í¾çÀÌ Æ¯À¯ÀÇ º´¿øÃ¼¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °í¾çÀÌ ºÎ¹®ÀÌ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
2024³â ºÏ¹Ì ¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀº ¾ö°ÝÇÑ ¹Ý·Áµ¿¹° ¹é½Å Á¢Á¾¹ý, ³ôÀº ¼öÀÇÇÐ ¼ºñ½º ÀÌ¿ë·ü, °·ÂÇÑ Á¦¾à R&DÀÇ Á¸Àç·Î ÀÎÇØ ºÏ¹Ì ¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀÌ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾ç ¹Ý·Áµ¿¹° ¹é½Å ½ÃÀåÀº ƯÈ÷ Áß±¹, Àεµ, µ¿³²¾Æ½Ã¾Æ µî ½ÅÈï±¹ÀÇ ¹Ý·Áµ¿¹° ¼ö°¡ ºü¸£°Ô Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
¼¼°è ÁÖ¿ä ½ÃÀå ±â¾÷À¸·Î´Â Zoetis,Zoetis,Merck & Co., Inc. Bimeda Biologicals, Neogen Corporation µîÀÌ ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼·Ð
Á¦2Àå ÁÖ¿ä ¿ä¾à
Á¦3Àå Á¶»ç ¹æ¹ý
Á¦4Àå ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå ÀλçÀÌÆ®
- ½ÃÀå ÇöȲ
- ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
- PESTEL ºÐ¼®
- ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå ÆÄ¿ö Æò°¡ µ¿Çâ
- ¹ë·ùüÀÎ ºÐ¼®
Á¦5Àå ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå : Á¦Ç°º°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ¾àµ¶È »ý¹é½Å
- ºÒÈ°È ¹é½Å
- ¾Æ´ÜÀ§ ¹é½Å
- DNA ¹é½Å
- ÀçÁ¶ÇÕ ¹é½Å
Á¦6Àå ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå : Åõ¿© °æ·Îº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ÇÇÇÏ
- ±ÙÀ°³»
- ºñ°³»
Á¦7Àå ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå : µ¿¹° À¯Çüº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- °³
- °í¾çÀÌ
- ±âŸ
Á¦8Àå ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå : À¯Åë ä³Îº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ¼Ò¸Å
- E-Commerce
- º´¿ø ¹× Ŭ¸®´Ð ¾à±¹
Á¦9Àå ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå : Áö¿ªº°
- ÁÖ¿ä Á¶»ç °á°ú
- ¼·Ð
- ¹Ý·Áµ¿¹°¿ë ¹é½Å ½ÃÀå ºÐ¼® : Áö¿ªº°, 2020³â-2034³â
- ºÏ¹Ì
- ºÏ¹Ì : Á¦Ç°º°, 2020-2034³â
- ºÏ¹Ì : Åõ¿© °æ·Îº°, 2020-2034³â
- ºÏ¹Ì : À¯Åë ä³Îº°, 2020-2034³â
- ºÏ¹Ì : µ¿¹° À¯Çüº°, 2020-2034³â
- ¹Ì±¹
- ij³ª´Ù
- À¯·´
- À¯·´ : Á¦Ç°º°, 2020-2034³â
- À¯·´ : Åõ¿© °æ·Îº°, 2020-2034³â
- À¯·´ : À¯Åë ä³Îº°, 2020-2034³â
- À¯·´ : µ¿¹° À¯Çüº°, 2020-2034³â
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ½ºÆäÀÎ
- ³×´ú¶õµå
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¾Æ½Ã¾ÆÅÂÆò¾ç : Á¦Ç°º°, 2020-2034³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : Åõ¿© °æ·Îº°, 2020-2034³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : À¯Åë ä³Îº°, 2020-2034³â
- ¾Æ½Ã¾ÆÅÂÆò¾ç : µ¿¹° À¯Çüº°, 2020-2034³â
- Áß±¹
- Àεµ
- ¸»·¹À̽þÆ
- ÀϺ»
- Àεµ³×½Ã¾Æ
- Çѱ¹
- È£ÁÖ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Á¦Ç°º°, 2020-2034³â
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : Åõ¿© °æ·Îº°, 2020-2034³â
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : À¯Åë ä³Îº°, 2020-2034³â
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : µ¿¹° À¯Çüº°, 2020-2034³â
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä« : Á¦Ç°º°, 2020-2034³â
- ¶óƾ¾Æ¸Þ¸®Ä« : Åõ¿© °æ·Îº°, 2020-2034³â
- ¶óƾ¾Æ¸Þ¸®Ä« : À¯Åë ä³Îº°, 2020-2034³â
- ¶óƾ¾Æ¸Þ¸®Ä« : µ¿¹° À¯Çüº°, 2020-2034³â
- ¸ß½ÃÄÚ
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
Á¦10Àå °æÀï ±¸µµ
- È®´ë¿Í Àμö ºÐ¼®
- Á¦ÈÞ/Çù¾÷/ÇÕÀÇ/°ø°³
Á¦11Àå ±â¾÷ °³¿ä
- Bimeda Biologicals
- Boehringer Ingelheim Animal Health
- Calier
- Ceva
- Elanco
- Merck & Co., Inc.
- Neogen Corporation
- Phibro Animal Health Corporation
- Virbac
- Zoetis
LSH
The companion animal vaccines market size is expected to reach USD 8,506.56 million by 2034, according to a new study by Polaris Market Research. The report "Companion Animal Vaccines Market Size, Share, Trends, & Industry Analysis Report: By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Product, By Animal Type, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The companion animal vaccines market comprises biologic products developed to protect domestic pets such as dogs, cats, and other non-livestock animals from various infectious diseases. This market continues to evolve as pet humanization intensifies and pet owners increasingly prioritize preventative healthcare. Advancements in veterinary immunology, coupled with rising awareness of zoonotic disease risks, are driving robust demand for both core and non-core vaccines. The industry is witnessing increased adoption of combination vaccines and novel delivery platforms, such as needle-free injectors and oral formulations, enhancing compliance and safety. Rising incidences of viral and bacterial infections in household animals have also catalyzed innovation in vaccine development, particularly in recombinant and DNA-based technologies.
The market growth is accelerated by the expansion of pet insurance coverage and greater veterinary healthcare expenditure, which collectively support higher vaccine uptake. Market players are investing in R&D to develop long-acting, cross-protective, and strain-specific vaccines, responding to evolving pathogen profiles and antigenic variability. Stringent regulatory oversight ensures product efficacy and safety, prompting manufacturers to integrate advanced quality assurance practices. Opportunities lie in personalized veterinary medicine and the application of artificial intelligence (AI) in vaccine development pipelines, which shorten time-to-market and improve targeting accuracy. The increasing role of veterinary clinics and digital health platforms in raising vaccine awareness, coupled with growing collaboration between pharmaceutical firms and veterinary institutions, signals a favorable outlook for market expansion.
Companion Animal Vaccines Market Report Highlights
By product, in 2024, the attenuated live vaccines segment held the largest share due to their robust immunogenicity and rapid onset of protection.
Based on animal type, the feline segment is expected to witness the highest CAGR during the forecast period due to increasing awareness around feline-specific pathogens such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).
In 2024, the North America companion animal vaccines market held the largest share due to the region's stringent pet vaccination laws, high veterinary service utilization, and strong pharmaceutical R&D presence.
The Asia Pacific companion animal vaccines market is projected to register the highest CAGR during the forecast period, driven by a rapidly growing pet population, particularly in emerging economies such as China, India, and Southeast Asia.
A few global key market players include Zoetis; Merck & Co., Inc.; Boehringer Ingelheim Animal Health; Elanco; Virbac; Phibro Animal Health Corporation; Calier; Ceva; Bimeda Biologicals; and Neogen Corporation.
Polaris Market Research has segmented the market report on the basis of product, route of administration, animal type, distribution channel, and region:
By Product Outlook (Revenue, USD Million, 2020-2034)
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Route of Administration Outlook (Revenue, USD Million, 2020-2034)
Subcutaneous
Intramuscular
Intranasal
By Animal Type Outlook (Revenue, USD Million, 2020-2034)
Canine
Feline
Others
By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)
Retail
E-Commerce
Hospital/Clinic Pharmacy
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Companion Animal Vaccines Market Insights
- 4.1. Companion Animal Vaccines Market - Market Snapshot
- 4.2. Companion Animal Vaccines Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Pet Ownership and Humanization of Pets
- 4.2.1.2. Growing Awareness About Zoonotic Diseases
- 4.2.2. Restraints and Challenges
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Companion Animal Vaccines Market Power Rating Trends
- 4.6. Value Chain Analysis
5. Companion Animal Vaccines Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Companion Animal Vaccines Market, by Product, 2020-2034 (USD Million)
- 5.3. Attenuated Live Vaccines
- 5.3.1. Companion Animal Vaccines Market, by Attenuated Live Vaccines, by Region, 2020-2034 (USD Million)
- 5.4. Inactivated Vaccines
- 5.4.1. Companion Animal Vaccines Market, by Inactivated Vaccines, by Region, 2020-2034 (USD Million)
- 5.5. Subunit Vaccines
- 5.5.1. Companion Animal Vaccines Market, by Subunit Vaccines, by Region, 2020-2034 (USD Million)
- 5.6. DNA Vaccines
- 5.6.1. Companion Animal Vaccines Market, by DNA Vaccines, by Region, 2020-2034 (USD Million)
- 5.7. Recombinant Vaccines
- 5.7.1. Companion Animal Vaccines Market, by Recombinant Vaccines, by Region, 2020-2034 (USD Million)
6. Companion Animal Vaccines Market, by Route of Administration
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 6.3. Subcutaneous
- 6.3.1. Companion Animal Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Million)
- 6.4. Intramuscular
- 6.4.1. Companion Animal Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Million)
- 6.5. Intranasal
- 6.5.1. Companion Animal Vaccines Market, by Intranasal, by Region, 2020-2034 (USD Million)
7. Companion Animal Vaccines Market, by Animal Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 7.3. Canine
- 7.3.1. Companion Animal Vaccines Market, by Canine, by Region, 2020-2034 (USD Million)
- 7.4. Feline
- 7.4.1. Companion Animal Vaccines Market, by Feline, by Region, 2020-2034 (USD Million)
- 7.5. Other
- 7.5.1. Companion Animal Vaccines Market, by Other, by Region, 2020-2034 (USD Million)
8. Companion Animal Vaccines Market, by Distribution Channel
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3. Retail
- 8.3.1. Companion Animal Vaccines Market, by Retail, by Region, 2020-2034 (USD Million)
- 8.4. E-Commerce
- 8.4.1. Companion Animal Vaccines Market, by E-Commerce, by Region, 2020-2034 (USD Million)
- 8.5. Hospital/ Clinic Pharmacy
- 8.5.1. Companion Animal Vaccines Market, by Hospital/ Clinic Pharmacy, by Region, 2020-2034 (USD Million)
9. Companion Animal Vaccines Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Companion Animal Vaccines Market Assessment, By Geography, 2020-2034 (USD Million)
- 9.3. Companion Animal Vaccines Market - North America
- 9.3.1. North America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.3.2. North America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.3.3. North America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.4. North America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.3.5. Companion Animal Vaccines Market - US
- 9.3.5.1. US: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.3.5.2. US: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.3.5.3. US: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.5.4. US: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.3.6. Companion Animal Vaccines Market - Canada
- 9.3.6.1. Canada: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.3.6.2. Canada: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.3.6.3. Canada: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.6.4. Canada: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4. Companion Animal Vaccines Market - Europe
- 9.4.1. Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.2. Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.3. Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.4. Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.5. Companion Animal Vaccines Market - UK
- 9.4.5.1. UK: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.5.2. UK: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.5.3. UK: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.5.4. UK: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.6. Companion Animal Vaccines Market - France
- 9.4.6.1. France: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.6.2. France: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.6.3. France: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.6.4. France: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.7. Companion Animal Vaccines Market - Germany
- 9.4.7.1. Germany: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.7.2. Germany: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.7.3. Germany: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.7.4. Germany: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.8. Companion Animal Vaccines Market - Italy
- 9.4.8.1. Italy: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.8.2. Italy: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.8.3. Italy: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.8.4. Italy: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.9. Companion Animal Vaccines Market - Spain
- 9.4.9.1. Spain: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.9.2. Spain: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.9.3. Spain: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.9.4. Spain: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.10. Companion Animal Vaccines Market - Netherlands
- 9.4.10.1. Netherlands: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.10.2. Netherlands: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.10.3. Netherlands: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.10.4. Netherlands: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.11. Companion Animal Vaccines Market - Russia
- 9.4.11.1. Russia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.11.2. Russia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.11.3. Russia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.11.4. Russia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.12. Companion Animal Vaccines Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.12.2. Rest of Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.12.3. Rest of Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.12.4. Rest of Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5. Companion Animal Vaccines Market - Asia Pacific
- 9.5.1. Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.5. Companion Animal Vaccines Market - China
- 9.5.5.1. China: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.5.2. China: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.5.3. China: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.5.4. China: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.6. Companion Animal Vaccines Market - India
- 9.5.6.1. India: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.6.2. India: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.6.3. India: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.6.4. India: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.7. Companion Animal Vaccines Market - Malaysia
- 9.5.7.1. Malaysia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.7.2. Malaysia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.7.3. Malaysia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.7.4. Malaysia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.8. Companion Animal Vaccines Market - Japan
- 9.5.8.1. Japan: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.8.2. Japan: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.8.3. Japan: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.8.4. Japan: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.9. Companion Animal Vaccines Market - Indonesia
- 9.5.9.1. Indonesia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.9.2. Indonesia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.9.3. Indonesia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.9.4. Indonesia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.10. Companion Animal Vaccines Market - South Korea
- 9.5.10.1. South Korea: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.10.2. South Korea: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.10.3. South Korea: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.10.4. South Korea: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.11. Companion Animal Vaccines Market - Australia
- 9.5.11.1. Australia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.11.2. Australia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.11.3. Australia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.11.4. Australia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.12. Companion Animal Vaccines Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.12.2. Rest of Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.12.3. Rest of Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.12.4. Rest of Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6. Companion Animal Vaccines Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.5. Companion Animal Vaccines Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.5.2. Saudi Arabia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.5.3. Saudi Arabia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.5.4. Saudi Arabia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.6. Companion Animal Vaccines Market - UAE
- 9.6.6.1. UAE: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.6.2. UAE: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.6.3. UAE: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.6.4. UAE: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.7. Companion Animal Vaccines Market - Israel
- 9.6.7.1. Israel: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.7.2. Israel: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.7.3. Israel: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.7.4. Israel: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.8. Companion Animal Vaccines Market - South Africa
- 9.6.8.1. South Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.8.2. South Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.8.3. South Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.8.4. South Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.9. Companion Animal Vaccines Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.9.2. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.9.3. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.9.4. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7. Companion Animal Vaccines Market - Latin America
- 9.7.1. Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.2. Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.3. Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.4. Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.5. Companion Animal Vaccines Market - Mexico
- 9.7.5.1. Mexico: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.5.2. Mexico: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.5.3. Mexico: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.5.4. Mexico: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.6. Companion Animal Vaccines Market - Brazil
- 9.7.6.1. Brazil: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.6.2. Brazil: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.6.3. Brazil: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.6.4. Brazil: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.7. Companion Animal Vaccines Market - Argentina
- 9.7.7.1. Argentina: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.7.2. Argentina: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.7.3. Argentina: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.7.4. Argentina: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.8. Companion Animal Vaccines Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.8.2. Rest of Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.8.3. Rest of Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.8.4. Rest of Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Bimeda Biologicals
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Boehringer Ingelheim Animal Health
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Calier
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Ceva
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Elanco
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Merck & Co., Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Neogen Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Phibro Animal Health Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Virbac
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Zoetis
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development